North America Joint Pain Injection Market is estimated to grow at a CAGR of 8.7% during forecast period 2022-2028

The joint pain injection market in North America is expected to grow from US$ 2,785.42 million in 2021 to US$ 5,010.47 million by 2028; it is estimated to grow at a CAGR of 8.7% from 2021 to 2028. Countries in North America are emerging as attractive outsourcing locations for pharmaceuticals and biopharmaceuticals industries. Flourishing domestic pharmaceutical market and increasing number of pipeline drugs are further opening new avenues for the contract manufacturers as well as generic drug manufacturing in the region. Additionally, to meet the growing demand, many contract-based organizations are expanding their manufacturing capabilities. Thus, the emerging markets hold high potential and huge revenue generation opportunities for the pharmaceutical manufacturing companies. According to a report published by the US Department of Health & Human Services in the year 2018 stated that near 700,000 knee replacement surgeries in US are being carried out every year. It is also expected that the number is likely to reach approximately 3.48 million surgeries per year till 2030.

Get Sample PDF@: https://www.businessmarketinsights.com/sample/TIPRE00024545?utm_source=OpenPR&utm_medium=10279

key companies profiled in this research study are: 
Chugai Pharmaceutical Co., Ltd.
Bioventus Inc.
Fidia Pharma USA Inc.
Flexion Therapeutics, Inc.
Seikagaku Corporation
Ferring B.V.
Sanofi
Anika Therapeutics, Inc.
OrthogenRx, Inc.
Teva Pharmaceutical Industries Ltd.

North America Joint Pain Injection Market Segmentation

North America Joint Pain Injection Market -By Drugs
Hyaluronic Acid
Corticosteroid
Others

North America Joint Pain Injection Market -By Joint Type
Knee
Foot and Ankle
Shoulder and Elbow
Hip
Others

North America Joint Pain Injection Market -By Distribution Channel
Retail Pharmacies
Hospitals Pharmacies
Others

North America Joint Pain Injection Market - By Country
US
Canada
Mexico

Our Sample Report Accommodate a Brief Introduction of the research report, TOC, List of Tables and Figures, Competitive Landscape and Geographic Segmentation, Innovation and Future Developments Based on Research Methodology

The reports cover key developments in the North America Joint Pain Injection Market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for the expansion of business and customer base of market players.

Access full Report Description, TOC, Table of Figure, Chart, etc. @: https://www.businessmarketinsights.com/reports/north-america-joint-pain-injection-market?utm_source=OpenPR&utm_medium=10279

In North America, especially the US witnessed an unprecedented rise in the number of COVID-19 cases, which led to the discontinuation of several business operations and manufacturing activities of various healthcare products, including joint pain injections, which negatively impacted the joint pain injection market. In order to manage the outbreak, government took preventive measures including total lockdowns and social distancing policies. In addition, medical device industry is also facing negative impact of this pandemic. As the COVID-19 pandemic continues to unfold, medical device companies are finding difficulties in managing their operations. Cancelling elective surgeries to reduce exposure to COVID-19 in the hospital and operating rooms into intensive care units is also negatively affecting the growth of the joint pain injection market. However, at end of second quarter, restrictions on orthopedic procedures were lifted by the US government and patients were also allowed to visit orthopedic offices. Such decisions helped market players to recover their losses during the pandemic.

Business Market Insights dedicated research and analysis team consist of experienced professionals with advanced statistical expertise and offer various customization options in the existing study.

Purchase a copy of this Report@: https://www.businessmarketinsights.com/buy/single/TIPRE00024545?utm_source=OpenPR&utm_medium=10279

Major Features of North America Joint Pain Injection Market Report:
Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America Joint Pain Injection Market.
Highlights key business priorities in order to assist companies to realign their business strategies.
The key findings and recommendations highlight crucial progressive industry trends in the North America Joint Pain Injection Market, thereby allowing players across the value chain to develop effective long-term strategies.
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
Scrutinize in-depth North America market trends and outlook coupled with the factors driving the market, as well as those hindering it.
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution

Contact us:
If you have any questions about this report or would like further information, please contact us:
Contact person: Sameer Joshi
Email: sales@businessmarketinsights.com
Phone: +1646791707
Blog URL: https://bmiinsights.blogspot.com/

About Us:
Business Market Insights is a market research platform that provides subscription service for industry and company reports. Our research team has extensive professional expertise in domains such as Electronics & Semiconductor; Aerospace & Defense; Automotive & Transportation; Energy & Power; Healthcare; Manufacturing & Construction; Food & Beverages; Chemicals & Materials; and Technology, Media, & Telecommunications.

This release was published on openPR.